Published in Curr Cardiol Rev on May 01, 2010
Exosomal miRNAs as potential biomarkers of cardiovascular risk in children. J Transl Med (2014) 0.96
Recent advances in cardiovascular proteomics. J Proteomics (2012) 0.84
Obesity alters molecular and functional cardiac responses to ischemia/reperfusion and glucagon-like peptide-1 receptor agonism. Basic Res Cardiol (2016) 0.75
Cardiovascular consequences of metabolic syndrome. Transl Res (2017) 0.75
High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45
Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol (2001) 28.01
Use of proteomic patterns in serum to identify ovarian cancer. Lancet (2002) 16.38
The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics (2002) 16.08
Nucleolar proteome dynamics. Nature (2005) 7.32
Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell (2003) 6.77
Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell (2006) 5.72
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med (2001) 5.50
Current two-dimensional electrophoresis technology for proteomics. Proteomics (2004) 4.87
Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc Natl Acad Sci U S A (2007) 4.80
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene (2001) 4.40
Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science (2008) 4.32
MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat Methods (2007) 4.20
The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications. Methods (2005) 3.71
Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science (2003) 3.64
Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol Cell Proteomics (2007) 3.60
Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A (2005) 3.55
Role of the mitochondrial permeability transition in myocardial disease. Circ Res (2003) 3.26
Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation (2005) 3.16
The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem (2005) 2.64
Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics (2002) 2.24
Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ Res (2006) 2.20
Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am J Physiol Endocrinol Metab (2004) 2.03
Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol (2008) 2.01
Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation (2007) 1.95
The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem (2006) 1.95
Analysis of the mouse liver proteome using advanced mass spectrometry. J Proteome Res (2007) 1.93
PRISM, a generic large scale proteomic investigation strategy for mammals. Mol Cell Proteomics (2003) 1.91
Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum (2004) 1.82
Mass spectrometric detection of tissue proteins in plasma. Mol Cell Proteomics (2006) 1.76
Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry. Mol Cell Proteomics (2008) 1.73
Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation (2003) 1.68
Stress echocardiography: comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol (1995) 1.61
Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease: a dobutamine stress echocardiography study. Circulation (2005) 1.53
A straightforward and highly efficient precipitation/on-pellet digestion procedure coupled with a long gradient nano-LC separation and Orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteome. J Proteome Res (2009) 1.46
Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis (2005) 1.37
Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol Cell Proteomics (2007) 1.31
Quantitative profile of five murine core proteomes using label-free functional proteomics. Mol Cell Proteomics (2007) 1.24
Increases in serum unbound free fatty acid levels following coronary angioplasty. Am J Cardiol (1996) 1.23
Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry. Clin Chem (2003) 1.22
The role of proteomics in clinical cardiovascular biomarker discovery. Mol Cell Proteomics (2008) 1.19
Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol (2006) 1.19
Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics. Proteomics (2006) 1.17
Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. J Mol Cell Cardiol (2007) 1.15
MALDI mass spectrometry for direct tissue analysis: a new tool for biomarker discovery. J Proteome Res (2005) 1.14
Quantification of protein expression changes in the aging left ventricle of Rattus norvegicus. J Proteome Res (2009) 1.13
Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis (1999) 1.12
Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats. Proteomics (2008) 1.08
Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics (2003) 1.07
Myocardial preconditioning and remote renal preconditioning--identifying a protective factor using proteomic methods? Basic Res Cardiol (2005) 1.06
Proteomics of the heart: unraveling disease. Circ Res (2006) 1.05
Use of 2-D DIGE analysis reveals altered phosphorylation in a tropomyosin mutant (Glu54Lys) linked to dilated cardiomyopathy. Proteomics (2008) 1.04
Mechanistic insights into nitrite-induced cardioprotection using an integrated metabolomic/proteomic approach. Circ Res (2009) 1.03
Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol (2003) 0.97
Quality control of serum albumin depletion for proteomic analysis. Clin Chem (2007) 0.96
Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy. Proteomics (2005) 0.94
Proteomic analysis of left ventricular remodeling in an experimental model of heart failure. J Proteome Res (2008) 0.91
Proteomic profiling of KATP channel-deficient hypertensive heart maps risk for maladaptive cardiomyopathic outcome. Proteomics (2009) 0.91
Proteomics of heart disease. Hum Mol Genet (2003) 0.89
Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis. Proteomics (2008) 0.88
SELDI-TOF MS analysis of the Cardiac Troponin I forms present in plasma from patients with myocardial infarction. Proteomics (2006) 0.88
Proteome analysis of isolated perfused organ effluent as a novel model for protein biomarker discovery. J Proteome Res (2006) 0.88
Proteomic analysis of mammalian basic proteins by liquid-based two-dimensional column chromatography. Proteomics (2006) 0.88
Proteomic analysis reveals significant elevation of heat shock protein 70 in patients with chronic heart failure due to arrhythmogenic right ventricular cardiomyopathy. Mol Cell Biochem (2009) 0.88
Alterations of mitochondrial enzymes contribute to cardiac hypertrophy before hypertension development in spontaneously hypertensive rats. J Proteome Res (2009) 0.88
MudPIT analysis: application to human heart tissue. Methods Mol Biol (2009) 0.87
Protein microarrays: challenges and promises. Pharmacogenomics (2002) 0.86
Biomarker discovery by proteomics: challenges not only for the analytical chemist. Analyst (2006) 0.86
Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling. FASEB J (2004) 0.86
Optimizing protein solubility for two-dimensional gel electrophoresis analysis of human myocardium. Proteomics (2003) 0.86
Intregrated analysis of the human cardiac transcriptome, proteome and phosphoproteome. Proteomics (2004) 0.85
Proteomics analysis of changes in myocardial proteins during endotoxemia. J Proteomics (2009) 0.84
Global protein shotgun expression profiling of proliferating mcf-7 breast cancer cells. J Proteome Res (2005) 0.84
Role of cardiac biomarkers (troponin I and CK-MB) as predictors of quality of life and long-term outcome after cardiac surgery. Ann Card Anaesth (2009) 0.84
Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes. Toxicology (2009) 0.84
Human aortic intima protein composition during initial stages of atherogenesis. Atherosclerosis (1986) 0.81
Effective depletion of albumin using a new peptide-based affinity medium. Proteomics (2005) 0.81
Two-dimensional gel electrophoresis for analysis of protein complexes. Methods Mol Biol (2004) 0.80
Going global: protein expression profiling using shotgun mass spectrometry. Curr Opin Mol Ther (2003) 0.79
A proteomic primer for the clinician. Proc Am Thorac Soc (2007) 0.77
SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol (2011) 2.84
Pathway analysis of dilated cardiomyopathy using global proteomic profiling and enrichment maps. Proteomics (2010) 1.29
Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways. J Am Heart Assoc (2013) 1.00
Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells. Circulation (2009) 0.97
Cathepsin-L contributes to cardiac repair and remodelling post-infarction. Cardiovasc Res (2010) 0.94
Targeted protein identification, quantification and reporting for high-resolution nanoflow targeted peptide monitoring. J Proteomics (2012) 0.76
Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype. Circ Res (2009) 0.75
Large-scale studies to identify biomarkers for heart disease: a role for proteomics? Expert Opin Med Diagn (2009) 0.75